CNC Quantitative Stock Analysis

Centene Corp (CNC), a large-cap healthcare facilities stock, received a 72% rating from Validea's Peter Lynch-inspired P/E/Growth Investor model, which prioritizes reasonable valuation relative to earnings growth and strong balance sheets. While CNC passed key metrics such as its Yield Adjusted P/E to Growth (PEG) ratio, Earnings Per Share, and Total Debt/Equity ratio, its overall score falls below the 80% threshold typically indicating investor interest for this strategy, with Inventory to Sales failing and Free Cash Flow and Net Cash Position being neutral.

Analysis

Centene Corp (CNC), a large-cap value stock in the healthcare facilities sector, scores a 72% based on a Peter Lynch-inspired quantitative model from Validea, which seeks growth at a reasonable price (GARP) coupled with a strong balance sheet. This rating is noteworthy as it falls below the 80% threshold that typically indicates significant interest from the strategy. The analysis reveals a mixed fundamental picture: CNC passes on key valuation and stability metrics, including its Yield Adjusted P/E to Growth (PEG) ratio, Earnings Per Share (EPS) performance, and Total Debt/Equity ratio, suggesting a reasonable price for its growth and a manageable debt load. However, the company fails the Inventory to Sales test, a potential red flag for operational efficiency or slowing demand. Furthermore, its Free Cash Flow and Net Cash Position are rated as neutral, indicating these are neither a source of significant strength nor a major weakness under this specific model's criteria. The overall assessment is that while CNC exhibits some attractive GARP characteristics, it does not fully meet the rigorous criteria of the Lynch model due to specific operational and balance sheet shortcomings.

Key Decisions for Investors

• Given the 72% score is below the model's 80% interest threshold, investors following a strict Peter Lynch GARP strategy should consider CNC a 'hold' or 'watchlist' candidate rather than a high-conviction 'buy'.
• The 'FAIL' rating on the Inventory to Sales ratio warrants further due diligence; investors should investigate whether this points to a systemic issue with demand, pricing power, or operational inefficiency.
• Positive signals from the PEG ratio, EPS, and moderate debt levels may still appeal to investors, but they must weigh these against the neutral cash flow metrics and the noted inventory concern.
• Monitor future reports for any improvement in Free Cash Flow and Net Cash Position, as positive momentum in these neutral areas could materially improve the stock's profile within this investment framework.